We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
+5.91%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.18B
AUM Growth
+$259M
Cap. Flow
+$204M
Cap. Flow %
17.3%
Top 10 Hldgs %
25.61%
Holding
1,947
New
328
Increased
686
Reduced
553
Closed
262

Sector Composition

Rank Sector Weight
1 Financials 12.77%
2 Technology 12.48%
3 Healthcare 9.89%
4 Consumer Discretionary 8.62%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRN icon
1101
Stride
LRN
$3.32B
$11K ﹤0.01%
712
+545
+326% +$9.07K
OIS icon
1102
Oil States International
OIS
$501M
$11K ﹤0.01%
394
-19,934
-98% -$483K
OLP
1103
One Liberty Properties
OLP
$527M
$11K ﹤0.01%
+432
New +$11.1K
PHX
1104
DELISTED
PHX Minerals
PHX
$11K ﹤0.01%
540
+461
+584% +$10.3K
VEEV icon
1105
Veeva Systems
VEEV
$35.4B
$11K ﹤0.01%
191
-4,230
-96% -$249K
VPG icon
1106
Vishay Precision Group
VPG
$906M
$11K ﹤0.01%
436
+396
+990% +$10K
WLFC icon
1107
Willis Lease Finance
WLFC
$1.35B
$11K ﹤0.01%
1,314
-321
-20% -$2.67K
WNC icon
1108
Wabash National
WNC
$512M
$11K ﹤0.01%
548
-6,769
-93% -$141K
RPT
1109
Rithm Property Trust
RPT
$94.2M
$11K ﹤0.01%
+138
New +$11.4K
MANT
1110
DELISTED
Mantech International Corp
MANT
$11K ﹤0.01%
222
+189
+573% +$9.18K
HSTO
1111
DELISTED
Histogen Inc. Common Stock
HSTO
$11K ﹤0.01%
+12
New +$11.1K
ADMS
1112
DELISTED
Adamas Pharmaceuticals
ADMS
$11K ﹤0.01%
319
+33
+12% +$921
JAX
1113
DELISTED
J. Alexander's Holdings, Inc.
JAX
$11K ﹤0.01%
1,129
+582
+106% +$6.04K
MLNT
1114
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$11K ﹤0.01%
+145
New +$10.7K
DFRG
1115
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$11K ﹤0.01%
690
-203
-23% -$2.88K
DST
1116
DELISTED
DST Systems Inc.
DST
$11K ﹤0.01%
175
-1,012
-85% -$60.1K
AZTA icon
1117
Azenta
AZTA
$1.42B
$10K ﹤0.01%
424
-2,192
-84% -$62.2K
BMRC icon
1118
Bank of Marin Bancorp
BMRC
$465M
$10K ﹤0.01%
280
+150
+115% +$5.18K
BRC icon
1119
Brady Corp
BRC
$4.63B
$10K ﹤0.01%
265
-238
-47% -$9.16K
CATO icon
1120
Cato Corp
CATO
$65.9M
$10K ﹤0.01%
606
-346
-36% -$5.01K
CLPR
1121
Clipper Realty
CLPR
$45.2M
$10K ﹤0.01%
1,050
+163
+18% +$1.72K
FFIC
1122
DELISTED
Flushing Financial
FFIC
$10K ﹤0.01%
372
-401
-52% -$11.5K
IDCC icon
1123
InterDigital
IDCC
$8.47B
$10K ﹤0.01%
126
-30
-19% -$2.24K
ILMN icon
1124
Illumina
ILMN
$29.3B
$10K ﹤0.01%
+45
New +$9.26K
KW
1125
DELISTED
Kennedy-Wilson Holdings
KW
$10K ﹤0.01%
593
+503
+559% +$9.47K

Similar funds

Meeder Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Meeder Asset Management held 1,947 positions worth $1.18B, up 28% from $918M the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Meeder Asset Management deployed $204M of net new capital in Q4 2017, opening 328 new positions and adding to 686 existing holdings. Its largest new stake was Vanguard Total Bond Market: 183,017 shares worth $14.9M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $5.55M trimmed.

  • Meeder Asset Management's largest Q4 2017 buy was Vanguard Total Bond Market: 183,017 shares worth $14.9M.
  • Meeder Asset Management added most to iShares 7-10 Year Treasury Bond ETF in Q4 2017, an estimated $52.8M increase.
  • Meeder Asset Management's biggest Q4 2017 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $5.55M.
  • Meeder Asset Management fully exited Fidelity National Financial in Q4 2017, selling an estimated $4.63M.
  • Meeder Asset Management's ten largest holdings make up 26% of its $1.18B portfolio in Q4 2017.
  • Meeder Asset Management opened 328 new positions and closed 262 in Q4 2017.
  • Meeder Asset Management's portfolio value rose 28% quarter-over-quarter to $1.18B.

Based on Meeder Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.